Get started
Author

Sameh Mikhail

Observed names: S Mikhail, S. MIKHAIL, S. Mikhail
Observed institutions: Mayo Clinic, Cairo University, Imperial College Healthcare NHS Trust, Georgetown University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Georgetown University Medical Center, Hammersmith Hospital, MedStar Georgetown University Hospital, The Ohio State University Wexner Medical Center, St Mary's Hospital, Rochester General Hospital, Mayo Clinic in Arizona, Mayo Clinic Hospital, Mark H. Zangmeister Cancer Center, Ruane Medical, Cairo University hospitals, Georgetown Lombardi Comprehensive Cancer Center, Imperial College London, The Ohio State University
ORCID: 0000-0003-3408-871X
Observed ORCID: 0000-0003-3408-871X
OpenAlex ID: A5010739819
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative
2018 · Michael J. Pishvaian, Robert J. Bender, et al. · Clinical Cancer Research · 245
Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry
2014 · Peter J. Ruane, Dani Ain, et al. · Journal of Hepatology · 167
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
2016 · Anne M Noonan, Matthew R Farren, et al. · Molecular Therapy · 166
PDF
Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program
2019 · Michael J. Pishvaian, Edik M. Blais, et al. · JCO Precision Oncology · 103
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer
2015 · Matthew R. Farren, Thomas A. Mace, et al. · Clinical Cancer Research · 102
Biomarkers of Angiogenesis in Colorectal Cancer
2015 · Luay Mousa, Mohamed E. Salem, et al. · Biomarkers in Cancer · 85
PDF
Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England
2016 · Sheraz R. Markar, Hugh Mackenzie, et al. · Gastric Cancer · 78
PDF
The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre
2007 · S. MIKHAIL, R. VARADARAJAN, et al. · Haemophilia · 77
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis
2016 · Daniel H. Ahn, Kavya Krishna, et al. · Therapeutic Advances in Medical Oncology · 59
PDF
Hepatocellular carcinoma: systemic therapies and future perspectives
2014 · Sameh Mikhail, David Cosgrove, et al. · Expert Review of Anticancer Therapy · 50
Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance
2016 · Daniel H. Ahn, Milind Javle, et al. · Cancer · 49
PDF
Radiofrequency assisted liver resection: Analysis of 604 consecutive cases
2011 · M. Pai, A.E. Frampton, et al. · European Journal of Surgical Oncology · 47
von Willebrand Disease in the Pediatric and Adolescent Population
2010 · Sameh Mikhail, Peter Kouides · Journal of Pediatric and Adolescent Gynecology · 37
Liver Cancer Stem Cells
2011 · Sameh Mikhail, Aiwu Ruth He · International Journal of Hepatology · 36
PDF
Improving the standard of lymph node retrieval after gastric cancer surgery
2013 · George B Hanna, Iakovos Amygdalos, et al. · Histopathology · 33
Cyclin-Dependent Kinase Inhibitors and the Treatment of Gastrointestinal Cancers
2015 · Sameh Mikhail, Christopher Albanese, et al. · American Journal Of Pathology · 32
PDF
Multi-omic molecular comparison of primary versus metastatic pancreatic tumours
2019 · Gagandeep Brar, Edik M. Blais, et al. · British Journal of Cancer · 30
PDF
Phase Ib/II study of cancer stem cell (CSC) inhibitor BBI608 combined with paclitaxel in advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma.
2015 · Carlos Becerra, Joe Stephenson, et al. · Journal of Clinical Oncology · 30
Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer
2012 · N. Shivapurkar, S. Mikhail, et al. · International Journal of Colorectal Disease · 29
PDF
Modified gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer (MPC): A single-institution experience.
2015 · Kavya Krishna, Marlo A. Blazer, et al. · Journal of Clinical Oncology · 22
Outcomes in pancreatic adenocarcinoma (PDA) patients (pts) with genetic alterations in DNA damage repair (DDR) pathways: Results from the Know Your Tumor (KYT) program.
2019 · Michael J. Pishvaian, Edik Matthew Blais, et al. · Journal of Clinical Oncology · 21
Outcomes of definitive chemoradiation in patients with esophageal cancer
2016 · Sameh Mikhail, Lai Wei, et al. · Diseases of the Esophagus · 21
An update on type 2B von Willebrand disease
2014 · Sameh Mikhail, Ehab Saad Aldin, et al. · Expert Review of Hematology · 18
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
2024 · Jordan M. Cloyd, Angela Sarna, et al. · JAMA Surgery · 17
Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
2020 · Christina Wu, Terence M. Williams, et al. · Clinical Cancer Research · 17
Works count: 113
Citation count: 1,805
H-index: 21
I10-index: 35
Year
Topic
Type